Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Blanco O, Perez-Gil J. Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: role of the different components in an efficient pulmonary surfactant. Eur J Pharmacol. 2007;568:1–15.
El Shahed AI, Dargaville P, Ohlsson A, Soll RF. Surfactant for meconium aspiration syndrome in full term/near term infants. Cochrane Database Syst Rev. 2007;(3):CD002054.
Finer NN, Merritt TA, Bernstein G, Job L, Mazela J, Segal R. An open label, pilot study of Aerosurf® combined with nCPAP to prevent RDS in preterm neonates. J Aerosol Med Pulm Drug Deliv. 2010;23:303–9.
Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J. 1999;13:1455–76.
Jobe AH. Pharmacology review: why surfactant works for respiratory distress syndrome. NeoReviews. 2006;7:e95–106.
Kribs A, Hartel C, Kattner E, et al. Surfactant without intubation in preterm infants with respiratory distress: first multi-center data. Klin Paediatr. 2010;222:13–7.
Lally KP, Lally PA, Langham MR, Hirschl R, et al. Congenital Diaphragmatic Hernia Study Group. Surfactant does not improve survival rate in preterm infants with congenital diaphragmatic hernia. J Pediatr Surg. 2004;39:829–33.
Laughon M, Bose C, Moya F, et al. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia. Pediatrics. 2009;123(1):89–96.
Morley CJ, Davis PG, Doyle LW, et al. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med. 2008;358:700–8.
Moya F, Gadzinowski J, Bancalari E, et al. A multicenter, randomized, masked comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics. 2005;115:1018–29.
Moya F, Javier MC. Myth. All surfactants are alike. Semin Fetal Neonatal Med. 2011;16(5):269–74.
Moya F, Maturana A. Animal-derived surfactants versus past and current synthetic surfactants: current status. Clin Perinatol. 2007;34:145–77.
Notter RH. Lung surfactant: basic science and clinical applications. New York: Marcel Dekker Inc.; 2000.
Perez-Gil J, Keough KM. Interfacial properties of surfactant proteins. Biochim Biophys Acta. 1998;1408:203–17.
Pfister RH, Soll R, Wiswell TE. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. Cochrane Database Syst Rev. 2009;(4):CD006180.
Pfister RH, Soll RF, Wiswell T. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Cochrane Database Syst Rev. 2007;(4):CD006069.
Sandri F, Plavka R, Ancore G, et al. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics. 2010;125:e1402–9.
Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database of Syst Rev 2009;2:Art. No.: CD007836. doi:10.1002/14651858.CD007836.
Sinha SK, Lacaze-Masmonteil T, Valls I, Soler A, et al. A randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics. 2005;115:1030–8.
Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2007;(4):CD003063.
SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Network. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;362:1970–8.
Whitsett JA, Weaver TE. Hydrophobic surfactant proteins in lung function and disease. N Engl J Med. 2002;347:2141–8.
Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol. 2005;5:58–68.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Moya, F., Javier, MC. (2012). Surfactant Replacement Therapy. In: Donn, S., Sinha, S. (eds) Manual of Neonatal Respiratory Care. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-2155-9_51
Download citation
DOI: https://doi.org/10.1007/978-1-4614-2155-9_51
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-2154-2
Online ISBN: 978-1-4614-2155-9
eBook Packages: MedicineMedicine (R0)